Skip to main content

Table 5 Univariable and multivariable associations of glaucoma related quality of life with clinical characteristics

From: The impact of glaucoma on quality of life in Ethiopia: a case-control study

Variable

Domain

Central and near vision

Outdoor Mobility

Peripheral vision

Dark adaptation and glare

Overall score

Mean

(95% CI)

Mean

(95% CI)

Mean

(95% CI)

Mean

(95% CI)

Mean

(95% CI)

Duration of diagnosis

 < 1 year

4.9

(4.3–5.4)

2.7

(2.3–3.0)

16.2

(14.2–18.2)

14.7

(13.4–16.0)

38.5

(34.6–42.3)

 1–5 years

6.5

(5.2–7.7)

3.5

(2.7–4.1)

20.7

(16.3–25.1)

18.9

(16.1–21.7)

49.6

(41.2–57.9)

 > 5 years

6.5

(4.9–8.0)

3.1

(2.1–3.9)

16.3

(12.9–23.8)

17.0

(13.5–20.6)

35.0

(34.4–55.4)

P valueac

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

P valueb

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

Duration of treatment

 < 1 year

6.0

(5.6–6.4)

3.0

(2.8–3.2)

18.7

(17.2–20.1)

16.8

(15.9–17.7)

44.5

(41.8–47.3)

 1–5 years

6.1

(5.1–7.1)

3.4

(2.9–3.9)

20.1

(16.5–23.6)

18.1

(16.5–21.1)

48.5

(41.6–55.3)

 > 5 years

6.5

(5.0–8.1)

3.0

(2.1–3.8)

19.9

(14.3–25.3)

16.6

(13.1–20.3)

46.1

(35.3–56.8)

P valuead

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

P valueb

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

Visual acuity

 Normal

4.8

(4.4–5.2)

2.5

(2.3–2.7)

15.2

(13.6–16.7)

14.8

(13.8–15.9)

37.3

(34.3–40.2)

 Moderate VI

6.3

(5.3–7.3)

3.4

(2.9–4.0)

20.5

(17.0–24.3)

18.7

(16.1–21.2)

49.1

(42.1–56.0)

 Severe VI

7.4

(6.3–8.6)

3.7

(3.0–4.3)

21.7

(17.6–25.9)

19.6

(16.8–22.5)

52.5

(44.5–60.4)

 Blind

9.7

(7.9–11.4)

4.9

(3.8–5.9)

32.0

(25.5–38.4)

23.9

(19.6–28.3)

70.5

(58.1–82.8)

P valuea

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

P valueb

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

Glaucoma stage

 Early

5.3

(4.9–5.7)

2.8

(2.6–3.1)

16.9

(15.3–18.4)

16.2

(15.1–17.2)

41.2

(38.2–44.2)

 Moderate

6.6

(5.4–7.8)

3.2

(2.6–3.9)

19.9

(15.7–24.0)

18.4

(15.6–21.2)

48.2

(40.1–56.2)

 Advanced

6.7

(5.6–7.7)

3.5

(2.9–4.2)

21.8

(17.9–25.5)

19.0

(16.4–21.4)

50.9

(43.6–58.3)

P valuea

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

P valueb

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

  1. VI visual impairment
  2. a P-values from univariable linear regression analysis
  3. b P-values from multivariable linear regression analysis
  4. c P-value results are for duration of diagnosis 1–5 years
  5. d P-value results are for duration of treatment 1–5 years
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us